Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Chlamydia trachomatis infection

Chlamydia trachomatis infection

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chlamydia trachomatis infection

6 trials tracked for Chlamydia trachomatis infection: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 114 citations.

6Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 1 Other / NA 4
  1. Phase 4 Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP Completed · 114 cited
  2. Phase 3 Phase 2B/3 Double-blinded Placebo-controlled Completed · 19 cited
  3. N/A Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT Completed
  4. N/A GonoScreen: Efficacy of Screening STIs in MSM Completed
  5. N/A Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences Completed
  6. N/A Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Chlamydia trachomatis infection: what the trials found

Doxycycline is an established treatment for Chlamydia trachomatis infection 1.

The intervention EVO100 demonstrated significant efficacy in treating urogenital infections. Specifically, it showed a statistically significant reduction in the number of cases for both Urogenital CT Infection (14 vs. 28; p=0.0256) and Urogenital GC Infection (2 vs. 9; p=0.0316) 2.

Recent results — preliminary, needs further review

  • Azithromycin was evaluated for compliance to receive CT or NG treatment and cure rates at 3 months, but these findings are not yet corroborated 5.
  • The use of GeneXpert for Chlamydia trachomatis and Neisseria gonorrhoeae screening is currently under investigation 3.
  • Nucleic acid amplification test 1 was evaluated for NG and CT detection 6.
  • Data regarding the incidence rates of Ng Plus Ct detected at any site and symptomatic cases were observed in a study comparing screened vs. non-screened individuals 4.

For the clinician treating this condition

  • Doxycycline is an established pharmacological option for managing Chlamydia trachomatis 1.
  • EVO100 has demonstrated statistically significant results in reducing urogenital CT and GC infections compared to standard measures 2.

AI synthesis of 6 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.